Cansino Biologics Inc(688185) 2021 achieved a net profit of 1.914 billion yuan, turning losses into profits year-on-year

Cansino Biologics Inc(688185) issue annual report. In 2021, the company realized an operating revenue of 4299702000 yuan, an increase of 1717482% over the same period of last year; The net profit attributable to the shareholders of the parent company was 19143900 yuan, turning losses into profits year-on-year. Last year's loss was 396638 thousand yuan. The basic earnings per share is 7.74 yuan. The company plans to distribute a cash dividend of 8 yuan (including tax) to all shareholders for every 10 shares.